(hematuria), which may make urine look pink, red, or cola-colored.
While many historical claims have been settled, legal discussions continue regarding newer cases or different types of injuries. You can find more information on legal rights through resources like Top Class Actions or RK Attorneys . 5. What Should You Do?
In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S.. ACTOS CANCER
In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug.
, such as needing to urinate more frequently or urgently. Pain during urination (dysuria). Pain in the lower back or pelvic region . 4. Legal Status and Claims (hematuria), which may make urine look pink, red,
Studies indicated that the risk increased with higher cumulative doses and longer duration of use (specifically more than 12 months).
Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer. In 2011, the FDA issued a safety communication
Actos is a brand-name prescription drug (generic name: ) manufactured by Takeda Pharmaceuticals . It belongs to a class of drugs called thiazolidinediones, designed to help adults with type 2 diabetes manage their blood sugar levels by improving insulin sensitivity. 2. The Connection to Bladder Cancer